Establishment of Nucleic Acid Amplification Technology for the Detection of Mycoplasma in Biological Products
Molecules · 23.05.2026 · 31 (11) · 1794
DOI: 10.3390/molecules31111794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 23.05.2026. Verfasst von Ying Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Food and Drug Control, No. 31 Huatuo St., Daxing District, Beijing 100050, China. Hauptthemen laut MEDLINE: Mycoplasma, Nucleic Acid Amplification Techniques, Biological Products. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Currently, the most commonly used methods for detecting Mycoplasma are the culture method and the indicator cell culture method. However, both approaches exhibit low sensitivity and are incapable of detecting low-concentration contamination. In addition, the detection period may extend up to 28 days, which is unsuitable for rapid screening and may delay timely contamination control measures. To address these limitations, a Mycoplasma detection method based on nucleic acid amplification technology (NAT) was developed following a comparative analysis of gene sequences from various Mycoplasma species. The method was validated with respect to its detection performance and its applicability to biological product samples. DNA was extracted from Mycoplasma-contaminated samples using a magnetic bead-based nucleic acid extraction method. Universal primers were designed based on the highly conserved 16S rRNA gene sequence of Mycoplasma, and amplification was performed using multiplex quantitative PCR (qPCR) with fluorescent probes. The limit of detection (LOD) was established based on statistics of 24 replicates. Method specificity and robustness were evaluated according to the guidelines set by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH Q2), while sample applicability was assessed in accordance with the European Pharmacopoeia (EP) . The NAT-based Mycoplasma detection method enabled rapid, qualitative identification of Mycoplasma contamination. The validated LOD was 10 CFU/mL, and the method met predefined requirements for sensitivity, specificity, and robustness. To assess applicability, real biological product samples, including monoclonal antibodies, antibody fusion proteins, bispecific antibodies, and trispecific antibodies, were spiked with 10 CFU/mL of standard Mycoplasma strains. All spiked samples tested positive. These findings confirm that the NAT-based Mycoplasma detection method is suitable for process control and product release testing in the production of biological products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute for Food and Drug Control, No. 31 Huatuo St., Daxing District, Beijing 100050, China.
- Yeasen Biotechnology (Shanghai) Co., Ltd., Building 1, Lane 166, Tianxiong Road, International Medical Park, Pudong New Area, Shanghai 201318, China.
- College of Science, Xi'an Jiaotong-Liverpool University, Room 111, Ren'ai Road, Dushu Lake Science and Education Innovation District, Suzhou Industrial Park, Suzhou 215123, China.
ORCID-Profile: Chenggang Liang
Zitieren
APA
Guo, Y., Qin, X., Zhang, J., Bi, H., Hou, S., Ding, Y., Pei, D., Li, X., Pan, Y., Sun, X., & Liang, C. (2026). Establishment of Nucleic Acid Amplification Technology for the Detection of Mycoplasma in Biological Products. Molecules, 31(11), 1794. https://doi.org/10.3390/molecules31111794
Vancouver
Guo Y, Qin X, Zhang J, Bi H, Hou S, Ding Y, et al. Establishment of Nucleic Acid Amplification Technology for the Detection of Mycoplasma in Biological Products. Molecules. 2026;31(11):1794. doi:10.3390/molecules31111794
BibTeX
@article{Guo2026,
author = {Guo, Ying and Qin, Xi and Zhang, Jing and Bi, Hua and Hou, Shuting and Ding, Youxue and Pei, Dening and Li, Xiang and Pan, Yue and Sun, Xiaoliang and Liang, Chenggang},
title = {Establishment of Nucleic Acid Amplification Technology for the Detection of Mycoplasma in Biological Products},
journal = {Molecules},
year = {2026},
volume = {31},
number = {11},
pages = {1794},
doi = {10.3390/molecules31111794}
}
EUVIMED